Skip to main content

EKOS™ Endovascular System

OPTALYSE study

OPTALYSE long-term data

Sustained RV remodeling & improved patient outcomes

In the OPTALYSE study which evaluated the optimal dose/duration of EKOS treatment, patients were followed for one year. In addition to showing quick improvement in RV function, the long-term data showed sustained RV remodeling out to one-year. OPTALYSE was also the first study of an interventional pulmonary embolism (PE) treatment to show improvement in patient quality of life outcomes.1

 

RV function

RV/LV ratio continued to reduce after 48h

p value <030001@365d

Graph of RV/LV reduction after 48 hours

Endurance

Mean 6-minute walk test distance

Graph of 6-minute walk test to measure endurance over 1 year

Physical functioning

Mean PROMUS-PF-6b scores

Graph of PROMUS-PF-6b scores for physical functioning over 1 year

Quality of life

Mean PEmb-QOL scores

Graph of Pemb-QOL scores for quality of life over 1 year
Filename
ekos-optalyse-clinical-trial.pdf
Size
790 KB
Format
application/pdf
Download the full OPTALYSE study
icon of open envelope with letter

Stay up to date

Receive emails on the latest advances, EKOS clinical data and news.

Sign up

 

Indications, safety and warnings

1. Tapson V et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism.  JACC: Cardiovascular Interventions 2018; 11(14):1401-1410.